Acumen Pharmaceuticals, Inc. Accounts Payable and Other Accrued Liabilities, Current
Acumen Pharmaceuticals, Inc. (ABOS) had Accounts Payable and Other Accrued Liabilities, Current of $2.75 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2023-05-09
- 2023-03-31: Accounts Payable and Other Accrued Liabilities, Current $2.75M.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities, Current $3.35M.
- 2022-09-30: Accounts Payable and Other Accrued Liabilities, Current $4.40M.
- 2022-06-30: Accounts Payable and Other Accrued Liabilities, Current $3.28M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-03-31 | $2.75M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $3.35M 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $4.40M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.28M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.58M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.91M 10-K · filed 2023-03-27 | $4.06M 10-K · filed 2022-03-28 |
| 2021-09-30 | $1.11M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.61M 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $423.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |